JP2006520367A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006520367A5 JP2006520367A5 JP2006505463A JP2006505463A JP2006520367A5 JP 2006520367 A5 JP2006520367 A5 JP 2006520367A5 JP 2006505463 A JP2006505463 A JP 2006505463A JP 2006505463 A JP2006505463 A JP 2006505463A JP 2006520367 A5 JP2006520367 A5 JP 2006520367A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- sulfonamide
- formula
- ethane
- isobutylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 C 1 -C 4 - acyloxy Chemical group 0.000 claims 21
- 150000001875 compounds Chemical class 0.000 claims 11
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 229940124530 sulfonamide Drugs 0.000 claims 6
- 150000003456 sulfonamides Chemical class 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 5
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 229910003827 NRaRb Inorganic materials 0.000 claims 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 150000002367 halogens Chemical class 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 claims 2
- 125000006726 (C1-C5) alkenyl group Chemical group 0.000 claims 1
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 1
- CDZXMZJMWAVHPX-MDZDMXLPSA-N (e)-2-(3-benzoylphenyl)ethenesulfonic acid Chemical compound OS(=O)(=O)\C=C\C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 CDZXMZJMWAVHPX-MDZDMXLPSA-N 0.000 claims 1
- UUZWUEBXQIRVIJ-CSKARUKUSA-N (e)-2-(3-propan-2-ylphenyl)prop-1-ene-1-sulfonamide Chemical compound CC(C)C1=CC=CC(C(\C)=C\S(N)(=O)=O)=C1 UUZWUEBXQIRVIJ-CSKARUKUSA-N 0.000 claims 1
- QQWFZCCLAXTVHT-BQYQJAHWSA-N (e)-2-[4-(2-methylpropyl)phenyl]ethenesulfonic acid Chemical compound CC(C)CC1=CC=C(\C=C\S(O)(=O)=O)C=C1 QQWFZCCLAXTVHT-BQYQJAHWSA-N 0.000 claims 1
- BUMBAHZDEXELLT-PKNBQFBNSA-N (e)-2-[4-(2-methylpropyl)phenyl]prop-1-ene-1-sulfonamide Chemical compound CC(C)CC1=CC=C(C(\C)=C\S(N)(=O)=O)C=C1 BUMBAHZDEXELLT-PKNBQFBNSA-N 0.000 claims 1
- BFFIVHMCADCVMV-VOTSOKGWSA-N (e)-2-[4-(methanesulfonamido)phenyl]ethenesulfonic acid Chemical compound CS(=O)(=O)NC1=CC=C(\C=C\S(O)(=O)=O)C=C1 BFFIVHMCADCVMV-VOTSOKGWSA-N 0.000 claims 1
- LMXBZKBMNSXXQO-AATRIKPKSA-N (e)-2-[4-(trifluoromethylsulfonyloxy)phenyl]ethenesulfonic acid Chemical compound OS(=O)(=O)\C=C\C1=CC=C(OS(=O)(=O)C(F)(F)F)C=C1 LMXBZKBMNSXXQO-AATRIKPKSA-N 0.000 claims 1
- HFFXLYHRNRKAPM-UHFFFAOYSA-N 2,4,5-trichloro-n-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(Cl)C=2)Cl)=N1 HFFXLYHRNRKAPM-UHFFFAOYSA-N 0.000 claims 1
- LZQJCFWBAWITPQ-UHFFFAOYSA-N 2-(3-benzoylphenyl)ethanesulfonic acid;2-(3-propan-2-ylphenyl)ethanesulfonic acid Chemical compound CC(C)C1=CC=CC(CCS(O)(=O)=O)=C1.OS(=O)(=O)CCC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 LZQJCFWBAWITPQ-UHFFFAOYSA-N 0.000 claims 1
- MARXMDRWROUXMD-UHFFFAOYSA-N 2-bromoisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(Br)C(=O)C2=C1 MARXMDRWROUXMD-UHFFFAOYSA-N 0.000 claims 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 claims 1
- LQVXSNNAFNGRAH-QHCPKHFHSA-N BMS-754807 Chemical compound C([C@@]1(C)C(=O)NC=2C=NC(F)=CC=2)CCN1C(=NN1C=CC=C11)N=C1NC(=NN1)C=C1C1CC1 LQVXSNNAFNGRAH-QHCPKHFHSA-N 0.000 claims 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- HGZTXQKHHIYWTQ-UHFFFAOYSA-N C(C)(=O)NS(=O)=O.C(C(C)C)C1=CC=C(C=C1)CC.CNS(=O)=O.CS(=O)(=O)NC1=CC=C(C=C1)CC.CNS(=O)=O.FC(S(=O)(=O)OC1=CC=C(C=C1)CC)(F)F Chemical compound C(C)(=O)NS(=O)=O.C(C(C)C)C1=CC=C(C=C1)CC.CNS(=O)=O.CS(=O)(=O)NC1=CC=C(C=C1)CC.CNS(=O)=O.FC(S(=O)(=O)OC1=CC=C(C=C1)CC)(F)F HGZTXQKHHIYWTQ-UHFFFAOYSA-N 0.000 claims 1
- XTTCTMIQWGKOMO-UHFFFAOYSA-N C=C.CNS(=O)=O Chemical compound C=C.CNS(=O)=O XTTCTMIQWGKOMO-UHFFFAOYSA-N 0.000 claims 1
- NPNAJCINLVHAJA-UHFFFAOYSA-N CC(C)Cc1ccc(cc1)C(C)S(O)(=O)=O.CC(c1ccc(cc1)N1Cc2ccccc2C1=O)S(O)(=O)=O Chemical compound CC(C)Cc1ccc(cc1)C(C)S(O)(=O)=O.CC(c1ccc(cc1)N1Cc2ccccc2C1=O)S(O)(=O)=O NPNAJCINLVHAJA-UHFFFAOYSA-N 0.000 claims 1
- FXPOJYPRVKTMAX-UHFFFAOYSA-N CN(C)CCCNS(=O)=O.FC(S(=O)(=O)OC1=CC=C(C=C1)CC)(F)F.CN(C)CCCNS(=O)=O.C(C1=CC=CC=C1)(=O)C=1C=C(C=CC1)CC Chemical compound CN(C)CCCNS(=O)=O.FC(S(=O)(=O)OC1=CC=C(C=C1)CC)(F)F.CN(C)CCCNS(=O)=O.C(C1=CC=CC=C1)(=O)C=1C=C(C=CC1)CC FXPOJYPRVKTMAX-UHFFFAOYSA-N 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 102000004890 Interleukin-8 Human genes 0.000 claims 1
- 108090001007 Interleukin-8 Proteins 0.000 claims 1
- 206010034277 Pemphigoid Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- 208000000594 bullous pemphigoid Diseases 0.000 claims 1
- 230000035605 chemotaxis Effects 0.000 claims 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 claims 1
- ZCRZCMUDOWDGOB-UHFFFAOYSA-N ethanesulfonimidic acid Chemical compound CCS(N)(=O)=O ZCRZCMUDOWDGOB-UHFFFAOYSA-N 0.000 claims 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 229940098779 methanesulfonic acid Drugs 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Substances CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 150000004965 peroxy acids Chemical class 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 230000010410 reperfusion Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 150000003460 sulfonic acids Chemical class 0.000 claims 1
- 150000003461 sulfonyl halides Chemical class 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims 1
- 229930192474 thiophene Natural products 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03005783A EP1457485A1 (en) | 2003-03-14 | 2003-03-14 | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| PCT/EP2004/050293 WO2004080951A2 (en) | 2003-03-14 | 2004-03-11 | Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006520367A JP2006520367A (ja) | 2006-09-07 |
| JP2006520367A5 true JP2006520367A5 (enExample) | 2007-05-10 |
| JP4578466B2 JP4578466B2 (ja) | 2010-11-10 |
Family
ID=32748883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006505463A Expired - Fee Related JP4578466B2 (ja) | 2003-03-14 | 2004-03-11 | スルホン酸類、その誘導体、およびそれらを含む医薬組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7737139B2 (enExample) |
| EP (2) | EP1457485A1 (enExample) |
| JP (1) | JP4578466B2 (enExample) |
| CN (1) | CN100372831C (enExample) |
| AT (1) | ATE547397T1 (enExample) |
| AU (1) | AU2004220360B2 (enExample) |
| CA (1) | CA2514988C (enExample) |
| DK (1) | DK1606248T3 (enExample) |
| ES (1) | ES2386811T3 (enExample) |
| NO (1) | NO332782B1 (enExample) |
| PT (1) | PT1606248E (enExample) |
| RU (1) | RU2345063C2 (enExample) |
| WO (1) | WO2004080951A2 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7504401B2 (en) | 2003-08-29 | 2009-03-17 | Locus Pharmaceuticals, Inc. | Anti-cancer agents and uses thereof |
| ES2238924B1 (es) | 2004-02-17 | 2006-12-01 | Investread Europa, S.L. | Uso del acido 2,5-dihidroxibencenosulfonico, en la fabricacion de medicamentos de aplicacion en el tratamiento de enfermedades angiodependientes. |
| US20080125485A1 (en) * | 2004-02-17 | 2008-05-29 | Action Medicines | Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis |
| US20070149618A1 (en) | 2004-02-17 | 2007-06-28 | Action Medicines, S.L. | Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| CA2573185A1 (en) | 2004-07-14 | 2006-02-23 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7645881B2 (en) | 2004-07-22 | 2010-01-12 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| TWI331523B (en) * | 2005-12-08 | 2010-10-11 | Nat Health Research Institutes | Vinylsulfonate compounds |
| DK2024329T3 (da) * | 2006-05-18 | 2013-11-04 | Dompe Spa | (2r)-2-[(4-sulfonyl)aminophenyl]propanamider og farmaceutiske sammensætninger indeholdende dem |
| WO2008020037A1 (en) | 2006-08-16 | 2008-02-21 | Action Medicines, S.L. | Use of 2,5-dihydroxybenzene derivatives for treating obesity, hirsutism, hypertricosis and viral warts |
| PT2056813E (pt) | 2006-08-16 | 2013-08-23 | Amderma Pharmaceuticals Llc | Compostos de 2,5-di-hidroxibenzeno para o tratamento da rosácea |
| EP2176233A1 (en) * | 2007-08-07 | 2010-04-21 | Schering Corporation | Gamma secretase modulators |
| CN103159674A (zh) * | 2013-04-03 | 2013-06-19 | 苏州安诺生物医药技术有限公司 | 2-苯烷酰胺类化合物及其制备方法、药物组合物和用途 |
| JP6568324B2 (ja) * | 2016-02-16 | 2019-08-28 | ゾエティス・サービシーズ・エルエルシー | ７Ｈ−ピロロ［２，３−ｄ］ピリミジン化合物の調製方法 |
| CN111747838B (zh) * | 2020-07-29 | 2023-04-07 | 深圳大学 | 一种电催化合成氘代布洛芬的方法 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL33051A (en) | 1968-10-11 | 1974-05-16 | Ciba Geigy Ag | Alpha-cycloalkenyl-phenyl-fatty acid derivatives and process for their manufacture |
| JPS4918875A (enExample) | 1972-06-17 | 1974-02-19 | ||
| NL7407668A (enExample) * | 1973-06-11 | 1974-12-13 | ||
| JPS5277030A (en) * | 1975-12-23 | 1977-06-29 | Toyo Pharma Kk | Production of novel benzyl sulphonic acid derivatives |
| IT1193955B (it) | 1980-07-22 | 1988-08-31 | Real Di Alberto Reiner S A S | Derivati ammidici dell'acido p-isobutilfenilpropionico, procedimento per la loro preparazione e relative composizioni farmaceutici |
| US5216026A (en) * | 1990-07-17 | 1993-06-01 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
| AU703557B2 (en) * | 1994-10-13 | 1999-03-25 | Pfizer Inc. | Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4' (LTB4) antagonists |
| EP0809492A4 (en) * | 1995-02-17 | 2007-01-24 | Smithkline Beecham Corp | IL-8 RECEPTOR ANTAGONISTS |
| US6262113B1 (en) * | 1996-03-20 | 2001-07-17 | Smithkline Beecham Corporation | IL-8 receptor antagonists |
| US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
| IT1298214B1 (it) | 1998-01-28 | 1999-12-20 | Dompe Spa | Sali dell'acido (r) 2-(3-benzoilfenil) propionico e loro composizioni farmaceutiche. |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| US6348032B1 (en) * | 1998-11-23 | 2002-02-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with benzimidazole derivatives |
| PE20001566A1 (es) * | 1999-03-26 | 2001-02-05 | Ucb Sa | Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas |
| US6774212B2 (en) * | 1999-12-03 | 2004-08-10 | Bristol-Myers Squibb Pharma Company | Alpha-ketoamide inhibitors of hepatitis C virus NS3 protease |
| IT1317826B1 (it) * | 2000-02-11 | 2003-07-15 | Dompe Spa | Ammidi, utili nell'inibizione della chemiotassi dei neutrofiliindotta da il-8. |
| IT1318466B1 (it) | 2000-04-14 | 2003-08-25 | Dompe Spa | Ammidi di acidi r-2-(amminoaril)-propionici, utili nella prevenzionedell'attivazione leucocitaria. |
| ITMI20010395A1 (it) * | 2001-02-27 | 2002-08-27 | Dompe Spa | Omega-amminoalchilammidi di acidi r-2-aril-propionici come inibitori della chemiotassi di cellule polimorfonucleate e mononucleate |
| ITMI20012025A1 (it) * | 2001-09-28 | 2003-03-28 | Dompe Spa | Sali di ammonio quaternari di omega-amminoalchilammidi di acidi r 2-aril-propionici e composizioni farmaceutiche che li contengono |
| ITMI20012434A1 (it) * | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
-
2003
- 2003-03-14 EP EP03005783A patent/EP1457485A1/en not_active Withdrawn
-
2004
- 2004-03-11 RU RU2005131846/04A patent/RU2345063C2/ru not_active IP Right Cessation
- 2004-03-11 CN CNB2004800068672A patent/CN100372831C/zh not_active Expired - Fee Related
- 2004-03-11 WO PCT/EP2004/050293 patent/WO2004080951A2/en not_active Ceased
- 2004-03-11 AU AU2004220360A patent/AU2004220360B2/en not_active Ceased
- 2004-03-11 US US10/544,396 patent/US7737139B2/en not_active Expired - Fee Related
- 2004-03-11 AT AT04719463T patent/ATE547397T1/de active
- 2004-03-11 EP EP04719463A patent/EP1606248B1/en not_active Expired - Lifetime
- 2004-03-11 JP JP2006505463A patent/JP4578466B2/ja not_active Expired - Fee Related
- 2004-03-11 PT PT04719463T patent/PT1606248E/pt unknown
- 2004-03-11 DK DK04719463.4T patent/DK1606248T3/da active
- 2004-03-11 ES ES04719463T patent/ES2386811T3/es not_active Expired - Lifetime
- 2004-03-11 CA CA2514988A patent/CA2514988C/en not_active Expired - Fee Related
-
2005
- 2005-10-11 NO NO20054672A patent/NO332782B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006520367A5 (enExample) | ||
| RU2315041C2 (ru) | Производные 2,6-хинолинила и 2,6-нафтила, фармацевтические композиции на их основе, их применение в качестве ингибиторов vla-4 и промежуточные соединения | |
| JP4782342B2 (ja) | フェノキシプロパノールアミン類、それらの製造方法およびそれらを含む医薬組成物 | |
| JP2008523069A5 (enExample) | ||
| JP2006501295A5 (enExample) | ||
| JP2016512822A5 (enExample) | ||
| JP2005504121A5 (enExample) | ||
| JP2007502804A5 (enExample) | ||
| RU2005131846A (ru) | Сульфоновые кислоты, производные указанных кислот и содержащие их фармацевтические композиции | |
| RU2006137272A (ru) | Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции | |
| JP2013526494A5 (enExample) | ||
| JP2008505171A5 (enExample) | ||
| AU2020257561B2 (en) | N-acyl-{4-((4-aryl-phenyl)sulfonylmethyl)piperidine} compounds and their therapeutic use | |
| ES2501640T3 (es) | Compuestos de bencenosulfonamidas, su método de síntesis y su uso en medicina | |
| JP2018529657A5 (enExample) | ||
| JP4393376B2 (ja) | フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用 | |
| JP2015504917A5 (enExample) | ||
| JP2009040767A5 (enExample) | ||
| ES2345983T3 (es) | Indazolamidas con actividad analgesica. | |
| JP2007519685A5 (enExample) | ||
| JP2006516592A5 (enExample) | ||
| TW201626993A (zh) | Ｎ-羥甲醯胺衍生物及含有其之醫藥 | |
| TW201041855A (en) | New process for preparing | |
| JP2013503170A5 (enExample) | ||
| JP2008520611A5 (enExample) |